Brigitte Rosenwirth
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
Papers in
- Virology 31
- HIV Research and Treatment 31
-
- HIV/AIDS drug development and treatment 27
- HIV/AIDS Research and Interventions 8
- Co-authors
- Erik De ClercqAndreas BillichP. PeichlJonathan L. HeeneyHans J. EggersR. DatemaJean‐Maurice DumontF Hammerschmid
- Journals
- Antiviral Research (12 papers)Virology (9 papers)Journal of Virology (9 papers)Journal of Medicinal Chemistry (7 papers)Antimicrobial Agents and Chemotherapy (6 papers)
- Partner nations
- AustriaGermanyNetherlands
In The Last Decade
Brigitte Rosenwirth
92 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 108
- Virology 899
- Infectious Diseases 781
- Hepatology 273
- Immunology 603
- Epidemiology 633
Countries citing papers authored by Brigitte Rosenwirth
This map shows the geographic impact of Brigitte Rosenwirth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Rosenwirth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Rosenwirth more than expected).
Fields of papers citing papers by Brigitte Rosenwirth
This network shows the impact of papers produced by Brigitte Rosenwirth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Rosenwirth. The network helps show where Brigitte Rosenwirth may publish in the future.
Co-authors
The 25 scholars most cited alongside Brigitte Rosenwirth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 5 | |
| 2 | 2006 | 223 | |
| 3 | 2006 | 12 | |
| 4 | Debio-025, a novel non-immunosuppressive cyclosporine analog with potent anti-human immunodeficiency virus type I activity: Pharmacological properties and mode of action | 2005 | 1 |
| 5 | 2005 | 64 | |
| 6 | 2000 | 15 | |
| 7 | 1997 | 21 | |
| 8 | 1997 | 35 | |
| 9 | 1996 | 3 | |
| 10 | 1996 | 11 | |
| 11 | 1996 | 34 | |
| 12 | 1996 | 15 | |
| 13 | 1994 | 8 | |
| 14 | 1994 | 44 | |
| 15 | 1994 | 34 | |
| 16 | 1992 | 56 | |
| 17 | 1992 | 6 | |
| 18 | 1991 | 9 | |
| 19 | Studies on the mechanism of antiviral action of 5-(2-chloroethyl)-2'-deoxyuridine against herpes-simplex virus | 1988 | 1 |
| 20 | 1987 | 2 |
About Brigitte Rosenwirth
Brigitte Rosenwirth is a scholar working on Virology, Infectious Diseases, Epidemiology, Cardiology and Cardiovascular Medicine and Immunology, having authored 93 papers that have together received 2.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (31 papers), HIV/AIDS drug development and treatment (27 papers), Viral Infections and Immunology Research (16 papers), Herpesvirus Infections and Treatments (13 papers), Virus-based gene therapy research (12 papers), Cytomegalovirus and herpesvirus research (12 papers), Signaling Pathways in Disease (10 papers) and HIV/AIDS Research and Interventions (8 papers). The work is most often cited by research in Virology (899 citations), Infectious Diseases (781 citations), Hepatology (273 citations), Immunology (603 citations) and Epidemiology (633 citations). Brigitte Rosenwirth has collaborated with scholars based in Austria, Germany and Netherlands. Frequent co-authors include Erik De Clercq, Andreas Billich, P. Peichl, Jonathan L. Heeney, Hans J. Eggers, R. Datema, Jean‐Maurice Dumont, F Hammerschmid, Peter ten Haaft and Piétro Scalfaro. Their work appears in journals such as Antiviral Research, Virology, Journal of Virology, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.